Company Overview

CapitalBio Corporation, a life science company, develops and commercializes biochip-related products for genomic, proteomic and cellomic research, bio-safety testing, and clinical applications. Its portfolio of biochips include infectious disease gene, drug resistance bacterial gene, cancer gene, non-invasive fetal diagnostic gene, genetic disease diagnostic gene, veterinary drug residue detection, forensic identification, drug screening, drug toxicity test, two-dimensional electrophoresis, single nucleotide polymorphisms detection gene, di-electrophoresis travelling wave pump, polysaccharide drug screening, neuron biophysical test, and stimulant drug test chips. The company also provides ar...

CapitalBio Corporation, a life science company, develops and commercializes biochip-related products for genomic, proteomic and cellomic research, bio-safety testing, and clinical applications. Its portfolio of biochips include infectious disease gene, drug resistance bacterial gene, cancer gene, non-invasive fetal diagnostic gene, genetic disease diagnostic gene, veterinary drug residue detection, forensic identification, drug screening, drug toxicity test, two-dimensional electrophoresis, single nucleotide polymorphisms detection gene, di-electrophoresis travelling wave pump, polysaccharide drug screening, neuron biophysical test, and stimulant drug test chips. The company also provides arrayers, hybridization and wash systems, and scanners; cell-network electrophysiological monitoring systems; microarray laboratory solutions; and research kits, research services, and microarray consumables. In addition, it offers scientific informatics and databases, such as software for controlling biochip instrumentation, data processing and data storage, and bioinformatic analysis; good agricultural practice information management systems for production and processing of medicinal herbs; structured electronic medical record systems; and medicinal herb compound database systems for drug discovery. Further, the company provides diagnostic products, such as M. tuberculosis drug resistance detection array kits, mycobacterial species identification array kits, mycobacterial detection real time PCR kits, human leukocyte antigen genotyping kits, human platelet antigen genotyping kits, and medical software solutions. Furthermore, it offers preparation and test kits for veterinary drug residue detection, beer spoilage bacterial DNA extraction, and foodborne pathogenic microorganisms’ detection applications; and food safety detection systems. CapitalBio Corporation was founded in 2000 and is based in Beijing, China. The company has subsidiaries in San Diego, California; and Hong Kong.

Key Executives for CapitalBio Corporation

Similar Private Companies By Industry

Recent Private Companies Transactions